Close the acquisition of Clario Holdings, Inc
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 29 Oct 2025
- Due
- 30 Jun 2026
- Delivered
- 24 Mar 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“The transaction is expected to be completed by the middle of 2026, subject to customary closing conditions and regulatory approvals.”
What we found
Evidence strength A What the grades mean
Later filings show Thermo Fisher completed the Clario acquisition on March 24, 2026, before the mid-2026 deadline.
-
A Thermo Fisher Scientific Inc. 8-K filed 2026-03-24
“Clario was acquired from a shareholder group led by Astorg and Nordic Capital, Novo Holdings and Cinven.” ✓ confirmed on the page
-
A Thermo Fisher Scientific Inc. 10-Q filed 2026-07-31
“On March 24, 2026, the company acquired, within the Laboratory Products and Biopharma Services segment, Clario Holdings, Inc., a U.S.-based leading provider of endpoint data solutions for clinical trials.” ✓ confirmed on the page
Market reaction: the shares moved +3.8% against the S&P 500 over the three sessions around the disclosure (23 Mar 2026 to 26 Mar 2026). What this measures
Checked 10 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Acquisition close
- Indicative materiality
- High rules
- Action
- Close
- Deliverable
- Acquisition of Clario Holdings, Inc.
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- Medium
- Conditional
- Yes: subject to customary closing conditions and regulatory approvals
- Depends on
- Regulatory, Counterparty
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Thermo Fisher Scientific Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-TMO-006024 · Corrections policy